{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:58:56Z","timestamp":1794092336673,"version":"4.8.0"},"reference-count":63,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2024,7,12]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the benefits and harms of deep brain stimulation for Parkinson\u2019s disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review with meta-analysis and trial sequential analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data sources<\/jats:title>\n                  <jats:p>Cochrane Central Register of Controlled Trials (CENTRAL), Medline, Embase, Latin American and Caribbean Health Sciences Literature (LILACS), and other sources, from inception to 9 May 2023.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                  <jats:p>Randomised clinical trials of deep brain stimulation with antiparkinsonian drug treatment use versus antiparkinsonian drugs only (primary comparison, seven trials) for Parkinson\u2019s disease. Other comparisons were deep brain stimulation versus surgery with sham stimulation (three trials) and versus resective surgery (two trials).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Primary outcomes were all cause mortality, serious adverse events, and disease specific symptoms. In seven trials, 1125 participants were randomised to receive deep brain stimulation with antiparkinsonian drugs versus antiparkinsonian drugs only. All results had a high risk of bias and the certainty of the evidence was very low for all primary outcomes. Information size was insufficient for assessing all cause mortality (risk ratio 2.69, 95% confidence interval (CI) 0.79 to 9.24; I<jats:sup>2<\/jats:sup>=0.0%; \u03c4<jats:sup>2<\/jats:sup>=0.00; P=0.12; four trials). Meta-analysis showed that deep brain stimulation increased the risk of serious adverse events (risk ratio 2.36, 95% CI 1.37 to 4.09; I<jats:sup>2<\/jats:sup>=73.7%; \u03c4<jats:sup>2<\/jats:sup>=0.24; P&lt;0.01; six trials) mainly because of an increased risk of perioperative complications, such as cerebral haemorrhages and postoperative confusion, and hardware related events, such as infection at the stimulator site, dislocation of the device, or reoperations. Meta-analyses indicated that deep brain stimulation might reduce some symptoms specific to Parkinson's disease, but assessment of disease specific symptoms in these trials had methodological limitations, including not reporting overall symptom scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The certainty of evidence was very low for all primary outcomes, and based on the included evidence, the beneficial effects were questionable because of methodological limitations. Compared with only antiparkinsonian drug treatment, deep brain stimulation with antiparkinsonian drugs seemed to increase the risk of serious adverse events, mainly because of perioperative complications and hardware related events. Conducting randomised clinical trials of adequate methodological quality to effectively evaluate the effects of deep brain stimulation is crucial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Systematic review registration<\/jats:title>\n                  <jats:p>PROSPERO CRD42022306556.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjmed-2023-000705","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T12:15:40Z","timestamp":1723896940000},"page":"e000705","source":"Crossref","is-referenced-by-count":24,"title":["Deep brain stimulation for Parkinson\u2019s disease: systematic review with meta-analysis and trial sequential analysis"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-1958","authenticated-orcid":false,"given":"Johanne Juul","family":"Petersen","sequence":"first","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-4694","authenticated-orcid":false,"given":"Caroline Barkholt","family":"Kamp","sequence":"additional","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Faltermeier","sequence":"additional","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Juul","sequence":"additional","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"},{"name":"Stolpegaard Psychotherapy Centre, Mental Health Services in the Capital Region of Denmark, Gentofte, Denmark"},{"name":"University of Copenhagen, Department of Psychology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemette","family":"L\u00f8kkegaard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg Hospital, Kobenhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Centre for Clinical Intervention Research, Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"2025080501032598000_3.1.e000705.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"2025080501032598000_3.1.e000705.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"2025080501032598000_3.1.e000705.3","doi-asserted-by":"publisher","DOI":"10.1159\/000314478"},{"key":"2025080501032598000_3.1.e000705.4","first-page":"504","article-title":"Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P T"},{"key":"2025080501032598000_3.1.e000705.5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00218-x"},{"key":"2025080501032598000_3.1.e000705.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360"},{"key":"2025080501032598000_3.1.e000705.7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.013912"},{"key":"2025080501032598000_3.1.e000705.8","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00415-022-10963-w","article-title":"Levodopa-induced dyskinesia: a historical review of parkinson\u2019s disease, dopamine, and modern advancements in research and treatment","volume":"269","author":"Hansen","year":"2022","journal-title":"J Neurol"},{"key":"2025080501032598000_3.1.e000705.9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.29.051605.112824"},{"key":"2025080501032598000_3.1.e000705.10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2741\/4586","article-title":"Deep brain stimulation: foundations and future trends","volume":"23","author":"Tierney","year":"2018","journal-title":"Front Biosci"},{"key":"2025080501032598000_3.1.e000705.11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnhum.2020.00162","article-title":"An international survey of deep brain stimulation utilization in Asia and oceania: the DBS think tank east","volume":"14","author":"Zhang","year":"2020","journal-title":"Front Hum Neurosci"},{"key":"2025080501032598000_3.1.e000705.12","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0282-08.2008"},{"key":"2025080501032598000_3.1.e000705.13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fneur.2019.00410","article-title":"Deep brain stimulation programming for movement disorders: current concepts and evidence-based strategies","volume":"10","author":"Koeglsperger","year":"2019","journal-title":"Front Neurol"},{"key":"2025080501032598000_3.1.e000705.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178984","article-title":"Adverse events in deep brain stimulation: a retrospective long-term analysis of neurological, psychiatric and other occurrences","volume":"12","author":"Buhmann","year":"2017","journal-title":"PLoS One"},{"key":"2025080501032598000_3.1.e000705.15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13643-022-02095-z","article-title":"Deep brain stimulation for neurological disorders: a protocol for a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"11","author":"Petersen","year":"2022","journal-title":"Syst Rev"},{"key":"2025080501032598000_3.1.e000705.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2025080501032598000_3.1.e000705.17","doi-asserted-by":"crossref","unstructured":"Higgins J , Thomas J , Chandler J . Cochrane handbook for systematic reviews of interventions. Cochrane, 2019. Available: https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"2025080501032598000_3.1.e000705.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2025080501032598000_3.1.e000705.19","unstructured":"ICH Harmonised Guideline . International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. 2015. Available: https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"2025080501032598000_3.1.e000705.20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-90"},{"key":"2025080501032598000_3.1.e000705.21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-120"},{"key":"2025080501032598000_3.1.e000705.22","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.96"},{"key":"2025080501032598000_3.1.e000705.23","unstructured":"Copenhagen Trial Unit. TSA - trial sequential analysis. 2021 Available: http:\/\/www.ctu.dk\/tsa"},{"key":"2025080501032598000_3.1.e000705.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.013"},{"key":"2025080501032598000_3.1.e000705.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.10.007"},{"key":"2025080501032598000_3.1.e000705.26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn188"},{"key":"2025080501032598000_3.1.e000705.27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn179"},{"key":"2025080501032598000_3.1.e000705.28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-86"},{"key":"2025080501032598000_3.1.e000705.29","unstructured":"Thorlund K , Engstr\u00f8m J , Brok J , et al . User manual for trial sequential analysis (TSA). 2011. Available: http:\/\/wwwctudk\/tsa\/files\/tsa_manualpdf"},{"key":"2025080501032598000_3.1.e000705.30","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s9242"},{"key":"2025080501032598000_3.1.e000705.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in cochrane meta-analyses with and without application of trial sequential analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"key":"2025080501032598000_3.1.e000705.32","unstructured":"McMaster University and Evidence Prime . GRADEpro GDT: gradepro guideline development tool. 2022. Available: https:\/\/www.gradepro.org\/"},{"key":"2025080501032598000_3.1.e000705.33","unstructured":"StataCorp . Stata statistical software: release 16. College Station, TX: StataCorp LLC, 2019."},{"key":"2025080501032598000_3.1.e000705.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060281"},{"key":"2025080501032598000_3.1.e000705.35","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317219"},{"key":"2025080501032598000_3.1.e000705.36","first-page":"267","article-title":"Neurosurgery at an earlier stage of parkinson disease: a randomized, controlled trial","volume":"68","author":"Sch\u00fcpbach","year":"2007","journal-title":"Neurol (ECronicon)"},{"key":"2025080501032598000_3.1.e000705.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.929"},{"key":"2025080501032598000_3.1.e000705.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70093-4"},{"key":"2025080501032598000_3.1.e000705.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205158"},{"key":"2025080501032598000_3.1.e000705.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.03.019"},{"key":"2025080501032598000_3.1.e000705.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002173420703"},{"key":"2025080501032598000_3.1.e000705.42","first-page":"201","article-title":"Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD","volume":"62","author":"Esselink","year":"2004","journal-title":"Neurol (ECronicon)"},{"key":"2025080501032598000_3.1.e000705.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70308-8"},{"key":"2025080501032598000_3.1.e000705.44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000475765","article-title":"Remotely programmed deep brain stimulation of the bilateral subthalamic nucleus for the treatment of primary parkinson disease: a randomized controlled trial investigating the safety and efficacy of a novel deep brain stimulation system","volume":"95","author":"Li","year":"2017","journal-title":"Stereotact Funct Neurosurg"},{"key":"2025080501032598000_3.1.e000705.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30108-3"},{"key":"2025080501032598000_3.1.e000705.46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2017.3762","article-title":"Bilateral deep brain stimulation of the nucleus basalis of meynert for parkinson disease dementia: a randomized clinical trial","volume":"75","author":"Gratwicke","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025080501032598000_3.1.e000705.47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JPD-212793","article-title":"Pedunculopontine and cuneiform nuclei deep brain stimulation for severe gait and balance disorders in parkinson\u2019s disease: interim results from a randomized double-blind clinical trial","volume":"12","author":"Bourilhon","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"2025080501032598000_3.1.e000705.48","unstructured":"Fahn S , Elton RL , et al . Unified parkinson\u2019s disease rating scale. In: Fahn S , Marsden CD , Calne D , eds. Recent developments in parkinson\u2019s disease. 1987: 153\u201363."},{"key":"2025080501032598000_3.1.e000705.49","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"2025080501032598000_3.1.e000705.50","unstructured":"Higgins J , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions version 6.2. 2022."},{"key":"2025080501032598000_3.1.e000705.51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025080501032598000_3.1.e000705.52","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj069"},{"key":"2025080501032598000_3.1.e000705.53","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-11-200112040-00010"},{"key":"2025080501032598000_3.1.e000705.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01085-X"},{"key":"2025080501032598000_3.1.e000705.55","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.295"},{"key":"2025080501032598000_3.1.e000705.56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mdc3.12632","article-title":"Minimal clinically important difference for UPDRS-III in daily practice","volume":"5","author":"S\u00e1nchez-Ferro","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"2025080501032598000_3.1.e000705.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.10.006"},{"key":"2025080501032598000_3.1.e000705.58","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20914"},{"key":"2025080501032598000_3.1.e000705.59","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7254-6"},{"key":"2025080501032598000_3.1.e000705.60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41531-021-00223-5","article-title":"Subthalamic and pallidal deep brain stimulation for parkinson\u2019s disease-meta-analysis of outcomes","volume":"7","author":"Lachenmayer","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"2025080501032598000_3.1.e000705.61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2018.08.017","article-title":"STN vs. GPI deep brain stimulation for tremor suppression in parkinson disease: a systematic review and meta-analysis","volume":"58","author":"Wong","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2025080501032598000_3.1.e000705.62","article-title":"Efficacy and safety of deep brain stimulation in the treatment of parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Bratsos","year":"2018","journal-title":"Cureus"},{"key":"2025080501032598000_3.1.e000705.63","article-title":"Trends and disparities in deep brain stimulation utilization in the united states: a nationwide inpatient sample analysis from 1993 to 2017","volume":"26","author":"Sarica","year":"2023","journal-title":"Lancet Reg Health Am"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2023-000705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:03:35Z","timestamp":1754381015000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2023-000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,17]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjmed-2023-000705"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2023-000705","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}